Atlas Trials

An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder

Clinical trial NCT00746967 · COMPLETED

Trial details

NCT number
NCT00746967
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sexual Dysfunctions, PsychologicalSexual Arousal Disorder
Start date
2003-01-01
Enrollment
267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.